#RT @aHUSAllianceAct: On 'feasibility of developing small-molecule or large-molecule #antibody #drugs by predicting the drug dosing & affinity requirements for potential #complement targets.' https://t.co/wMrsQuJGzA @FrontiersIn Complement Dynamics for
On 'feasibility of developing small-molecule or large-molecule #antibody #drugs by predicting the drug dosing & affinity requirements for potential #complement targets.' https://t.co/nbZrNUvyHo @FrontiersIn Complement Dynamics for Target Validation &am
“Mathematical Modeling of Complement Pathway Dynamics for Target Validation and Selection of Drug Modalities for Complement Therapies” https://t.co/HVEl8HH2oi #QSPmodel https://t.co/hbBNmUxOv5
New Research: Mathematical Modeling of Complement Pathway Dynamics for Target Validation and Selection of Drug Modalities for Complement Therapies https://t.co/HBShto6Nc7 #pharmacology